Aspiriant LLC’s Ameriprise Financial AMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Buy
672
+60
+10% +$27.5K 0.01% 313
2026
Q1
$272K Buy
+612
New +$295K 0.01% 292
2024
Q2
Sell
-946
Closed -$415K 286
2024
Q1
$415K Buy
946
+135
+17% +$54.1K 0.02% 213
2023
Q4
$308K Buy
+811
New +$278K 0.01% 235
2023
Q2
Sell
-805
Closed -$247K 285
2023
Q1
$247K Buy
+805
New +$264K 0.01% 243
2016
Q3
Sell
-2,022
Closed -$249K 184
2016
Q2
$249K Buy
+2,022
New +$195K 0.02% 166

Other funds holding AMP

Aspiriant LLC's AMP Position: Q2 2026 in Review

Aspiriant LLC increased its Ameriprise Financial (AMP) stake by 9.8% in Q2 2026, buying an estimated $27.5K and bringing the position to 672 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #313.

Aspiriant LLC first reported a position in AMP in Q2 2016 and has held it in 6 quarters since. The position peaked at $415K in Q1 2024. 1,381 funds tracked by Wall St. Rank hold AMP as of Q2 2026.

  • Aspiriant LLC held 672 shares of Ameriprise Financial worth $308K as of Q2 2026.
  • Aspiriant LLC bought 60 Ameriprise Financial shares in Q2 2026, an estimated $27.5K.
  • Ameriprise Financial made up 0.01% of Aspiriant LLC's portfolio in Q2 2026, its #313 holding.
  • Aspiriant LLC first reported a position in Ameriprise Financial in Q2 2016 and has held it in 6 quarters since.
  • Aspiriant LLC's Ameriprise Financial position peaked at $415K in Q1 2024.
  • 1,381 funds tracked by Wall St. Rank held Ameriprise Financial as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.